Wsfs Capital Management »

Cognition Therapeutics shares owned by Wsfs Capital Management

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Wsfs Capital Management from 13F filings

Historical chart of Wsfs Capital Management investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Wsfs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Wsfs Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $53k 40k 1.35
2025-06-30 $7.2k 23k 0.31
2025-03-31 $9.8k 23k 0.42
2024-12-31 $16k 23k 0.70

More positions owned by Wsfs Capital Management

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Microsoft Corporation (MSFT)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Oracle Corporation (ORCL)
Cisco Systems (CSCO)
Amazon (AMZN)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)

View all positions for Wsfs Capital Management

Top funds holding Cognition Therapeutics

BIOS Capital Management
Davenport & Co
Vanguard Group
Tang Capital Management
Chescapmanager
BlackRock
Jane Street
Renaissance Technologies
Geode Capital Management
Hilton Capital Management
Millennium Management
State Street Corporation
Voss Capital
Graham Capital Management
American Financial Group

View all funds holding Cognition Therapeutics